Abstract

30Jan 2017 PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF PROGRAMMED DEATH LIGAND (PD-L1) AND FOXP3 EXPRESSIONS IN TUMOR CELLS AND TUMOR MICROENVIRONMENT IN OVARIAN CANCER PATIENTS Lobna A. Abdelaziz , Shereen El Shorbagy , Ola M Elfarargy , Ola A. Harb , and Abeer M Abdelbary. Clinical Oncology and Nuclear Medicine Department , Faculty of Medicine, Zagazig University. Medical Oncology Department, Faculty of Medicine, Zagazig University. Pathology Department, Faculty of Medicine, Zagazig University.

Highlights

  • The microenvironment of epithelial ovarian cancerReceived: 29 November 2016 Final Accepted: 26 December 2016 Published: January 2017(EOC) continued to be an important point of research to discover new therapeutic targets for such malignancy

  • It was discovered that any cells that were in the microenvironment of the Epithelial ovarian cancer (EOC) may be associated with cancer prognosis like tumor-infiltrating lymphocytes (TILs) and T

  • The expressions of programmed death ligand 1 (PD-L1) and FOXP3 in both tumor cells and stromawere evaluated in sections of 50 paraffin blocks that were retrieved from 50 patients with EOC using immunohistochemistry.We assessed the relation between their expressions, clinicopathological parameters, survival and prognosis of those patients

Read more

Summary

Background

Received: 29 November 2016 Final Accepted: 26 December 2016 Published: January 2017. (EOC) continued to be an important point of research to discover new therapeutic targets for such malignancy. It was discovered that any cells that were in the microenvironment of the EOC may be associated with cancer prognosis like tumor-infiltrating lymphocytes (TILs) and T-. Epithelial ovarian cancer, microenvironment; PD-L1; FOXP3; prognosis regulatory cells (Tregs). Tregs (mature T lymphocytes) that start in the thymus after stimulation of naïve T cells and responsible for the reduction of autoimmune diseases, but its over production will inhibit endogenous protection against infection and tumors. It was found that Foxp is found in Treg cells that originated in the thymus and in malignant cells and its difference in expression can affect the outcome of cancer patients. Aim of our study: was to assess PD-L1 and FOXP3 expression in epithelial ovarian carcinoma a trial to detect their prognostic value and their impact on survival in patients with such type of cancer

Methods
Results
Patients and Methods
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.